Home › Mesothelioma › Nebraska › Omaha
Mesothelioma clinical trials in Omaha, NE
4 studies for Mesothelioma are looking for participants at sites in and around Omaha (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Lead-212 PSV359 Therapy for Patients With Solid Tumors
RecruitingPhase 1/2
- Nebraska Cancer Specialists, Omaha
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RecruitingPhase 1
- Nebraska Cancer Specialists, Omaha
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
RecruitingPhase 2
- University of Nebraska (Data collection only), Omaha
Integrated Cancer Repository for Cancer Research
RecruitingObservational studyHealthy volunteers welcome
- Methodist Estabrook Cancer Center, Omaha
- Nebraska Methodist Health System, Omaha
- University of Nebraska Medical Center, Omaha
- and 1 more
About Mesothelioma
Mesothelioma is a tumor of mesothelium, a tissue that lines lungs and other organs. Most people who get it have inhaled asbestos. Read the symptoms.
More about Mesothelioma on MedlinePlus
Mesothelioma trials in other cities
- Houston, TX16 studies
- New York City, NY11 studies
- Washington, DC9 studies
- Boston, MA9 studies
- Los Angeles, CA8 studies
- Nashville, TN8 studies
- Chicago, IL8 studies
- Arlington, VA6 studies
- Pittsburgh, PA6 studies
- Dallas, TX5 studies
- Edison, NJ5 studies
- Rochester, MN5 studies
Other studies in Omaha
- Prostate Cancer29 studies
- Non-Small Cell Lung Cancer25 studies
- Breast Cancer23 studies
- Cancer (all types)19 studies
- Colorectal Cancer18 studies
- Multiple Myeloma17 studies
- Ovarian Cancer15 studies
- Pancreatic Cancer15 studies
- Head and Neck Squamous Cell Carcinoma15 studies
- Metastatic Cancer14 studies
- Non-Hodgkin Lymphoma14 studies
- Lung Cancer13 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.